COVID‐19 vaccines mix‐and‐match: The concept, the efficacy and the doubts
The search for developing effective vaccines against SARS‐CoV‐2 began with the start of
the COVID‐19 pandemic, and the first vaccine dose was administered in December 2020 …
the COVID‐19 pandemic, and the first vaccine dose was administered in December 2020 …
New-age vaccine adjuvants, their development, and future perspective
In the present scenario, immunization is of utmost importance as it keeps us safe and
protects us from infectious agents. Despite the great success in the field of vaccinology …
protects us from infectious agents. Despite the great success in the field of vaccinology …
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 …
Background To date, no immunological data on COVID-19 heterologous vaccination
schedules in humans have been reported. We assessed the immunogenicity and …
schedules in humans have been reported. We assessed the immunogenicity and …
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
J Li, L Hou, X Guo, P Jin, S Wu, J Zhu, H Pan… - Nature medicine, 2022 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
and the waning of vaccine-elicited neutralizing antibodies suggests that additional …
and the waning of vaccine-elicited neutralizing antibodies suggests that additional …
[HTML][HTML] Controlling timing and location in vaccines
Vaccines are one of the most powerful technologies supporting public health. The adaptive
immune response induced by immunization arises following appropriate activation and …
immune response induced by immunization arises following appropriate activation and …
Role of senescence and aging in SARS-CoV-2 infection and COVID-19 disease
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has resulted in a global pandemic associated with substantial …
coronavirus 2 (SARS-CoV-2), has resulted in a global pandemic associated with substantial …
A 'mix and match'approach to SARS-CoV-2 vaccination
ME Deming, KE Lyke - Nature medicine, 2021 - nature.com
A ‘mix and match’ approach to SARS-CoV-2 vaccination | Nature Medicine Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited …
content Thank you for visiting nature.com. You are using a browser version with limited …
Cell penetrating peptides: the potent multi-cargo intracellular carriers
ABSTRACT Introduction: Cell penetrating peptides (CPPs) known as protein translocation
domains (PTD), membrane translocating sequences (MTS), or Trojan peptides (TP) are able …
domains (PTD), membrane translocating sequences (MTS), or Trojan peptides (TP) are able …
What does plant-based vaccine technology offer to the fight against COVID-19?
S Rosales-Mendoza, VA Márquez-Escobar… - Vaccines, 2020 - mdpi.com
The emergence of new pathogenic viral strains is a constant threat to global health, with the
new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS …
new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS …
mRNA-based vaccine for COVID-19: they are new but not unknown!
mRNA vaccines take advantage of the mechanism that our cells use to produce proteins.
Our cells produce proteins based on the knowledge contained in our DNA; each gene …
Our cells produce proteins based on the knowledge contained in our DNA; each gene …